Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousStem CellsWhole-Body IrradiationHematopoietic Stem Cell TransplantationBone and BonesHematopoietic Stem CellsAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBone Marrow PurgingBusulfanStem Cell TransplantationHistocompatibility TestingBone Marrow DiseasesHistocompatibilityHematopoiesisCyclophosphamideTransplantation, IsogeneicMice, Inbred C57BLBone Marrow ExaminationKidney TransplantationRadiation ChimeraRecurrenceCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow NeoplasmsHematologic NeoplasmsTime FactorsTreatment OutcomeRemission InductionImmunosuppressive AgentsCell DifferentiationPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionHepatic Veno-Occlusive DiseaseColony-Forming Units AssayBone RemodelingLeukemia, MyeloidTransplantation ImmunologyGraft vs Host ReactionLymphocyte DepletionImmunosuppressionLymphoma, Non-HodgkinAcute DiseaseLeukocyte TransfusionChimeraHeart TransplantationT-LymphocytesSevere Combined ImmunodeficiencyMyelodysplastic SyndromesSurvival AnalysisHLA AntigensRetrospective StudiesCells, CulturedHematologic DiseasesLung TransplantationCyclosporineFlow CytometryLymphocyte TransfusionActuarial AnalysisBone DensityMesenchymal Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPancytopeniaGranulocyte Colony-Stimulating FactorAntigens, CD34Nuclear FamilyCarmustineSpleenAdult Stem CellsLeukocyte CountGraft vs Tumor EffectCytarabineFollow-Up StudiesGraft vs Leukemia EffectOrgan TransplantationSurvival RateMice, Inbred BALB CCytomegalovirus InfectionsCell LineageMelphalanMultiple MyelomaCell SeparationBone ResorptionDisease-Free SurvivalHematopoietic Stem Cell MobilizationEtoposidePeripheral Blood Stem Cell TransplantationLymphomaMice, Knockout